1. Home
  2. SON vs BLCO Comparison

SON vs BLCO Comparison

Compare SON & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$50.79

Market Cap

4.9B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.24

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
BLCO
Founded
1899
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Containers/Packaging
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.4B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
SON
BLCO
Price
$50.79
$15.24
Analyst Decision
Buy
Buy
Analyst Count
9
11
Target Price
$60.13
$18.45
AVG Volume (30 Days)
1.3M
426.6K
Earning Date
04-21-2026
04-29-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
N/A
EPS
0.68
N/A
Revenue
$7,518,753,000.00
$5,101,000,000.00
Revenue This Year
$0.10
$8.65
Revenue Next Year
$1.82
$5.59
P/E Ratio
$74.21
N/A
Revenue Growth
41.72
6.47
52 Week Low
$38.65
$12.02
52 Week High
$58.44
$18.92

Technical Indicators

Market Signals
Indicator
SON
BLCO
Relative Strength Index (RSI) 54.57 46.74
Support Level $46.53 $15.20
Resistance Level $52.71 $15.67
Average True Range (ATR) 1.50 0.38
MACD 0.28 0.01
Stochastic Oscillator 73.13 53.81

Price Performance

Historical Comparison
SON
BLCO

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: